Friday, March 5, 2021
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
    • All Events
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
    • All Events
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

908 Devices Selected for Next-Gen Chemical Detection Program

by Global Biodefense Staff
May 20, 2015

908 Devices today announced that its High-Pressure Mass Spectrometry (HPMS) has been selected to move forward in the U.S. Army’s Next Generation Chemical Detector (NGCD) program.

Teaming for the NGCD program with Smiths Detection Inc., the two companies will jointly move into the next phase of technology development and testing. This Option I award, from the Joint Project Manager for Nuclear, Biological and Chemical Contamination Avoidance (JPM NBC CA), is a major milestone within the overall requirements for this program.

The NGCD program will provide capabilities to detect and identify Non-Traditional Agents (NTAs), Chemical Warfare Agents (CWAs), Toxic Industrial Chemicals (TICs), and other hazards in the air and on surfaces in all states of matter (aerosol, liquid, solid and vapor).

“We believe HPMS technology plays a key role in the future of threat detection,” said Dr. Kevin J. Knopp, President and CEO, 908 Devices. “We are thrilled to be part of the U.S. Army’s plan for next generation detectors. Our technology platform detects a broad range of priority threats in the presence of complex backgrounds and is suited to a variety of product form factors to meet specific mission sets.”

908 Devices’ high-pressure approach to mass spectrometry is the first of its kind, enabling technology considered the “gold standard” of the laboratory to be deployed in a rugged handheld form factor. Unlike other analytical techniques, mass spectrometry measures the mass of charged molecules providing extraordinary sensitivity and selectivity. This allows for rapid detection and identification of chemical threats even in the presence of background interferents.

HPMS refers to mass spectrometry without the need for the extreme vacuum required by a conventional mass spectrometer, enabling the device to become smaller and be powered more efficiently. Demonstrating these capabilities is the company’s flagship product, M908, employing HPMS to provide civilian users, first responders and military teams with unique capabilities for chemical analysis in the field.

Source: 908 Devices press release, adapted.

Tags: AwardsChemical Detection

Related Posts

UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx)
Funding News

UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx)

March 2, 2021
Rigel Awarded $16.5 Million from DoD for Phase 3 Trial of Fostamatinib in COVID-19 Patients
Funding News

Rigel Awarded $16.5 Million from DoD for Phase 3 Trial of Fostamatinib in COVID-19 Patients

January 30, 2021
Defense Threat Reduction Agency Awards $75M for Antibiotic Drug Development
Antimicrobial Resistance

Defense Threat Reduction Agency Awards $75M for Antibiotic Drug Development

January 26, 2021
Vaccine Approval Is Just The Beginning – Huge Production Challenges Await
Funding News

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

December 1, 2020
Load More

Latest News

Medical Countermeasure Development

2021 BAA for Development of Medical Countermeasures for Biological Threats

March 2, 2021
UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx)

UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx)

March 2, 2021
New Coronavirus Variant: Here Is What Scientists Know About B1525

New Coronavirus Variant: Here Is What Scientists Know About B1525

March 2, 2021
How Does the Johnson & Johnson Vaccine Compare to the Other Coronavirus Vaccines?

How Does the Johnson & Johnson Vaccine Compare to the Other Coronavirus Vaccines?

March 2, 2021

Upcoming Events

Mar 5
Virtual Event
March 2 - March 5

Effectiveness of Non-Vaccine Influenza Control Measures

Mar 6
Virtual Event
March 6 - March 10

CROI 2021 – Conference on Retroviruses and Opportunistic Infections

Mar 8
Virtual Event
March 8 - March 10

Quantum-Enabled Sensing and Imaging for Biology

Mar 8
Virtual Event
2:00 pm - 3:30 pm

TRB Webinar: Visualizing Effects of COVID-19 on Transportation: A One-Year Retrospective

Mar 9
Virtual Event
March 9 - March 11

The Current Global Governance Landscape for Influenza

View More
Tweets by GlobalBioD

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2021 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
    • All Events
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Subscribe

© 2021 Stemar Media Group LLC